EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Therapeutic Benefit of Upadacitinib in Severe Post-Proctectomy (Class 4) Perianal Crohn’s Disease: A Three-Patient Case Series

Luke Nathan Hanna iD, Baseer Quraishi, Theo Pelly, Phillip Lung, Phil Tozer iD, Ailsa Hart, Serre-Yu Wong iD, Nick Powell iD

Inflammatory Bowel Diseases · 2026

DOI: 10.1093/ibd/izaf216 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Inflammatory Bowel Diseases, 2026. Verfasst von Luke Nathan Hanna und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom. Hauptthemen laut MEDLINE: Crohn Disease, Heterocyclic Compounds, 3-Ring, Postoperative Complications, Proctectomy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This case series describes striking clinical and radiological responses in 3 Crohn’s disease patients with persistent perineal complications following proctectomy treated with upadacitinib. It highlights the potential of advanced therapies for this refractory inflammatory bowel disease phenotype with limited treatment options.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseHeterocyclic Compounds, 3-RingPostoperative ComplicationsProctectomyAdultFemaleHumansMaleTreatment Outcome

Stichwörter der Autor:innen

perianal Crohn’s diseaseperineal woundpersistent perineal sinusproctectomy outcomessmall moleculessurgical complicationsupadacitinib“Class 4”

Substanzen

Heterocyclic Compounds, 3-Ringupadacitinib

Autor:innen und Institutionen

  • Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom.
  • Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Department of Surgery, St Mark's Hospital & Academic Institute, London, United Kingdom.
  • Department of Radiology, St Mark's Hospital & Academic Institute, London, United Kingdom.
  • Department of Medicine, St Mark's Hospital & Academic Institute, London, United Kingdom.
  • The Dr Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

ORCID-Profile: Luke Nathan Hanna, Phil Tozer, Serre-Yu Wong, Nick Powell

Zitieren

APA

Hanna, L. N., Quraishi, B., Pelly, T., Lung, P., Tozer, P., Hart, A., Wong, S. Y., & Powell, N. (2026). Therapeutic Benefit of Upadacitinib in Severe Post-Proctectomy (Class 4) Perianal Crohn’s Disease: A Three-Patient Case Series. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaf216

Vancouver

Hanna LN, Quraishi B, Pelly T, Lung P, Tozer P, Hart A, et al. Therapeutic Benefit of Upadacitinib in Severe Post-Proctectomy (Class 4) Perianal Crohn’s Disease: A Three-Patient Case Series. Inflammatory Bowel Diseases. 2026. doi:10.1093/ibd/izaf216

BibTeX
@article{Hanna2026,
  author = {Hanna, Luke Nathan and Quraishi, Baseer and Pelly, Theo and Lung, Phillip and Tozer, Phil and Hart, Ailsa and Wong, Serre-Yu and Powell, Nick},
  title = {Therapeutic Benefit of Upadacitinib in Severe Post-Proctectomy (Class 4) Perianal Crohn’s Disease: A Three-Patient Case Series},
  journal = {Inflammatory Bowel Diseases},
  year = {2026},
  doi = {10.1093/ibd/izaf216}
}
Kostenlos starten →